1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Trisomy 8 in pediatric acute myeloid leukemia : A NOPHO-AML study
(
- Contribution to journal › Article
-
Mark
Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the nordic countries.
(
- Contribution to journal › Article
- 2015
-
Mark
The applicability of the WHO classification in paediatric AML. A NOPHO-AML study
(
- Contribution to journal › Article
-
Mark
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
(
- Contribution to journal › Article
- 2014
-
Mark
Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study
(
- Contribution to journal › Article
- 2013
-
Mark
Outcome of poor response paediatric AML using early SCT
(
- Contribution to journal › Article
- 2012
-
Mark
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
(
- Contribution to journal › Article
- 2011
-
Mark
Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate.
(
- Contribution to journal › Article
-
Mark
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
(
- Contribution to journal › Article
- 2009
-
Mark
Individualized 6-Mercaptopurine Increments During Consolidation Treatment Of Lower Risk Childhood All
(
- Contribution to journal › Published meeting abstract